Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Part 1 (US assessment in the supine position), Part 2 (US assessment after PLR).
- Who it may be relevant to
- Registry conditions: Inferior Vena Cava Imaging. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Artificial Intelligence or Human Hand? A Pilot Study Evaluating Inferior Vena Cava Imaging for Hydration Status - The THAP2 Study
Overview
This observational pilot project is to compare AI-guided sonographic IVC measurements with those of human operators (experienced sonographer, beginner sonographer) in two commonly used views (Subcostal (SC)), Right Intercostal (RI)) in healthy, euvolemic participants before and after PLR, which mimics hypervolemia, in order to assess the possible role of AI-guided sonographic IVC measurements by assessing its feasibility and reliability. Each participant will undergo a SC and a RI IVC US assessment before and after PLR by both sonographers, resulting in a total of 8 IVC US examinations with 8 additional AI-guided IVC indices assessments.
Detailed description
This observational pilot project is to compare AI-guided sonographic IVC measurements with those of human operators (experienced sonographer, beginner sonographer) in two commonly used views (SC, RI) in healthy, euvolemic participants before and after PLR, which mimics hypervolemia, in order to assess the possible role of AI-guided sonographic IVC measurements by assessing its feasibility and reliability. US assessment will be performed by two sonographers, one beginner (BS) and one experienced (ES), blinded to each other's measurements. The BS is defined as a doctor who has not performed more than 20 US assessments of the IVC and has not performed clinical US of the abdominal region (at least 1x/week) in the past 6 months. The ES is defined as a doctor who has performed at least 20 US assessments of the IVC and uses US at least 1x/week in the past 6 months. Both BS and ES will perform a 2-hour training session in IVC sonography in two views (SC, RI) with a US-experienced doctor and will have full access to the protocol and measurement techniques during the assessments. The study consists of a screening visit and a study visit, which can be performed on the same day, with at least 2 hours interval between the two.
Interventions
- Diagnostic test Part 1 (US assessment in the supine position)
IVC US assessment consists of two parts, repeated for both SC and RI views. The IVC is visualized according to either SC or RI view. A video capturing two complete respiratory cycles is recorded in B-mode and stored. Subsequently, the "Smart IVC" preset is selected, and an AI-guided measurement is obtained at the same anatomical point under identical conditions. For each examination, the sonographer places the probe to obtain an optimal assessment point for both human- and AI-guided measurements - Diagnostic test Part 2 (US assessment after PLR)
The participant's legs are elevated to 45° while the upper body remains horizontal (0°). After 2 minutes, the sonographer performs the US assessment following the same protocol as in Part 1. For each examination, the sonographer places the probe to obtain an optimal assessment point for both human- and AI-guided measurements. The time from examination start to achieving a satisfactory imaging window for both SC view and RI view in the supine position is recorded using a stopwatch.
Primary outcome measures
- Percentage of participants with IVC max >2.1 cm and IVC CI <50% in the SC view [Time frame: These assessments will take place on the same day; the study visit will last about 60 minutes]
Eligibility criteria
Inclusion criteria
- Healthy adults aged 18 years or older, 50% biological women
Exclusion criteria
- Pregnant or lactating women
- History of thrombosis of the inferior vena cava
- Major cardiovascular event in the last 3 months
- History of peripheral arterial disease of the legs
- History of heart failure of any grade
- History of atrial fibrillation or atrial flutter
- History of severe valvular disease
- History of renal failure
- History of liver cirrhosis
- History of chronic obstructive lung disease (COPD), chronic bronchitis, pulmonary emphysema
- History of diabetes mellitus
- History of arginine-vasopressin (AVP) disturbance
- Abdominal surgery within the last 3 month
- Volume loss (diarrhoea, vomiting, or bleeding) within the past 3 days
- Respiratory distress of any grade
- Any diuretic therapy, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs)
- Inability to follow procedures or insufficient proficiency in the study language
- Inability to provide informed consent
- Vital signs outside normal limits: tachycardia >100 bpm, systolic blood pressure <85 mmHg, or SpO2 < 92%
- Employees or colleagues in a direct supervisory, subordinate, or collaborative relationship with the study team
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
Switzerland · 1 center
- University Hospital Basel, Endocrinology, Diabetes and Metabolism — Basel
Identifiers
NCT: NCT07419048 · 2025-02478; kt26Potasso